Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-08-10 12:28 pm Purchase | 13G | NOVOCURE LTD NVCR | Capital International Investors | 10,709,062 10.3% | 2,271,587 (+26.92%) | View |
2021-05-10 12:49 pm Purchase | 13G | NOVOCURE LTD NVCR | Capital World Investors | 11,028,431 10.7% | 3,272,161 (+42.19%) | View |
2021-02-16 1:57 pm Purchase | 13G | NOVOCURE LTD NVCR | Capital International Investors | 8,437,475 8.3% | 8,437,475 (New Position) | View |
2021-02-16 12:14 pm Purchase | 13G | NOVOCURE LTD NVCR | Capital World Investors | 7,756,270 7.6% | 7,756,270 (New Position) | View |
2021-02-10 11:40 am Purchase | 13G | NOVOCURE LTD NVCR | VANGUARD GROUP INC | 8,243,970 8.1% | 990,600 (+13.66%) | View |
2021-02-08 10:29 am Sale | 13G | NOVOCURE LTD NVCR | FMR LLC | 9,645,386 9.473% | -2,534,042 (-20.81%) | View |
2021-02-05 08:03 am Purchase | 13G | NOVOCURE LTD NVCR | BlackRock Inc. BLK | 5,796,681 5.7% | 1,496,934 (+34.81%) | View |
2021-02-01 12:08 pm Sale | 13G | NOVOCURE LTD NVCR | Wyss Hansjoerg | 8,141,397 8% | -813,351 (-9.08%) | View |
2021-01-14 12:14 pm Purchase | 13G | NOVOCURE LTD NVCR | BAILLIE GIFFORD & CO | 8,261,075 8.12% | 252,093 (+3.15%) | View |
2020-12-21 4:02 pm Sale | 13D | NOVOCURE LTD NVCR | Perlhagen Gert L. | 4,829,200 4.74% | -1,170,800 (-19.51%) | View |
2020-07-10 10:39 am Sale | 13G | NOVOCURE LTD NVCR | BlackRock Inc. BLK | 4,299,747 4.3% | -1,433,570 (-25.00%) | View |
2020-02-18 09:12 am Purchase | 13G | NOVOCURE LTD NVCR | Capital World Investors | 5,035,320 5% | 5,035,320 (New Position) | View |
2020-02-12 11:01 am Purchase | 13G | NOVOCURE LTD NVCR | VANGUARD GROUP INC | 7,253,370 7.32% | 834,405 (+13.00%) | View |
2020-02-11 09:54 am Sale | 13G | NOVOCURE LTD NVCR | Wyss Hansjoerg | 8,954,748 9% | -1,000,000 (-10.05%) | View |
2020-02-07 11:26 am Purchase | 13G | NOVOCURE LTD NVCR | FMR LLC | 12,179,428 12.306% | 989,048 (+8.84%) | View |
2020-02-07 08:45 am Purchase | 13G | NOVOCURE LTD NVCR | BlackRock Inc. BLK | 5,733,317 5.8% | 976,917 (+20.54%) | View |
2020-01-22 09:15 am Purchase | 13G | NOVOCURE LTD NVCR | BAILLIE GIFFORD & CO | 8,008,982 8.09% | 8,008,982 (New Position) | View |
2019-05-10 1:49 pm Sale | 13G | NOVOCURE LTD NVCR | BlackRock Inc. BLK | 4,756,400 4.97% | -40,288 (-0.84%) | View |